Pure and Cure Healthcare Private Limited, a wholly-owned subsidiary of Akums Drugs and Pharmaceuticals Limited, has successfully executed a lease deed for a new industrial plot. Located at Plot No. 36, Sector 8A, IIE SIDCUL, Haridwar, the site spans approximately 4050 square meters. This strategic acquisition, finalized on April 28, 2026, is situated adjacent to the subsidiary’s existing manufacturing facility and is intended to support and scale its ongoing business operations.
Strategic Expansion in Haridwar
Akums Drugs and Pharmaceuticals Limited has announced a key infrastructure development for its wholly-owned subsidiary, Pure and Cure Healthcare Private Limited. On April 28, 2026, the subsidiary entered into a formal lease deed to acquire an industrial plot in Uttarakhand. The site, measuring approximately 4050 square meters, includes both land and building assets, positioning the subsidiary for enhanced operational capacity.
Operational Synergies and Future Growth
The newly acquired plot is strategically located at Plot No. 36, Sector 8A, IIE SIDCUL, Haridwar, directly adjacent to the existing manufacturing site currently operated by the subsidiary. By securing this contiguous space, the company aims to streamline its logistics and manufacturing workflows. This expansion is expected to provide the necessary physical infrastructure to support the subsidiary’s growing business requirements and improve overall production efficiency moving forward.
Source: BSE
